Literature DB >> 34853967

Simultaneous Administration of NOD-2 (MDP) and TLP-4 (LPS) Ligands to Bone Marrow Donors 24 h before Transplantation Increases the Content of Multipotent Stromal Cells (MSCs) in Bone Marrow Grafts in CBA Mice Compared to the Total Result of Their Isolated Administration.

Yu F Gorskaya1, E N Semenova2, E V Nagurskaya2, V A Bekhalo2, V G Nesterenko2.   

Abstract

In 3-month bone marrow transplants of CBA mice from bone marrow donors receiving single injections of TLR-4 ligand (LPS) or NOD-2 ligand (muramyl dipeptide, MDP) 24 h before transplantation, an increase in the total number of MSCs (by 2.6 and 1.9 times, respectively), as well as a slight increase in the number of nuclear cells and the mass of bone capsules (by 1.3 and 1.2 times) were observed. After combined administration of MDР and LPS to donors, the total content of MSCs in the grafts was higher by 1.6 times in comparison with the total result of their isolated administration (and by 7.2 times in comparison with the control). At the same time, the concentration of osteogenic MSCs in the grafts of all groups was almost the same and corresponded to the control level. The number of nuclear cells and the mass of bone capsules of the grafts after combined administration of LPS and MDP were close (~80%) to the sum of the results of their isolated administration. These findings suggest that activation of the stromal tissue and the success of bone marrow transplantation depend on the intensity of innate immune responses. These data can be useful for the development of optimal methods of tissue transplantation.
© 2021. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  MSCs; NLR and TLR ligands; immune response; transplantation

Mesh:

Substances:

Year:  2021        PMID: 34853967      PMCID: PMC8635759          DOI: 10.1007/s10517-021-05358-2

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  13 in total

1.  Counts of stromal precursor cells in the bone marrow and heterotopic bone marrow transplants from mice immunized with group A streptococcus antigens during different periods after immunization.

Authors:  U F Gorskaya; T A Danilova; V G Nesterenko
Journal:  Bull Exp Biol Med       Date:  2009-01       Impact factor: 0.804

2.  Effects of combined treatment with complex S. typhimurium antigens and factors stimulating osteogenesis (curettage, BMP-2) on multipotent bone marrow stromal cells and serum concentration of cytokines in CBA mice.

Authors:  Yu F Gorskaya; T A Danilova; A S Karyagina; V G Lunin; V I Grabko; M S Bartov; A V Gromov; T M Grunina; L A Soboleva; I M Shapoval; V G Nesterenko
Journal:  Bull Exp Biol Med       Date:  2015-02-24       Impact factor: 0.804

3.  The Content of Multipotent Stromal Cells in 3-4.5-Month Heterotopic Bone Marrow Transplants of CBA Mice Subjected to a Single Exposure to Osteogenic Stimuli (Curettage, BMP-2) or Antigens (S. typhimurium antigenic complex, LPS).

Authors:  Yu F Gorskaya; V G Nesterenko
Journal:  Bull Exp Biol Med       Date:  2017-06-03       Impact factor: 0.804

4.  Effect of immunization with polyvinylpyrrolidone on the counts of stromal precursor cells in bone marrow and spleen of CBA and CBA/N mice and cytokine gene expression in primary cultures of these cells.

Authors:  U F Gorskaya; T A Danilova; M V Mezentzeva; M M Shapoval; V G Nesterenko
Journal:  Bull Exp Biol Med       Date:  2012-05       Impact factor: 0.804

5.  In vivo formation of bone and haematopoietic territories by transplanted human bone marrow stromal cells generated in medium with and without osteogenic supplements.

Authors:  Sergei A Kuznetsov; Mahesh H Mankani; Pamela Gehron Robey
Journal:  J Tissue Eng Regen Med       Date:  2011-11-03       Impact factor: 3.963

6.  Ligands of NOD2 (Muramyl Dipeptide) and TLR4 (LPS) in 24 h after Combined In Vivo Administration Produce a Synergistic Increase in the Content of Multipotent Stromal Cells in the Bone Marrow and Peritoneal Exudate of CBA Mice.

Authors:  Yu F Gorskaya; A I Tukhvatulin; A Sh Dzharullaeva; V G Nesterenko
Journal:  Bull Exp Biol Med       Date:  2019-02-20       Impact factor: 0.804

7.  Synergistic enhancement of Toll-like receptor responses by NOD1 activation.

Authors:  David A van Heel; Subrata Ghosh; Matt Butler; Karen Hunt; Brian Michael J Foxwell; Dominique Mengin-Lecreulx; Raymond J Playford
Journal:  Eur J Immunol       Date:  2005-08       Impact factor: 5.532

8.  Combined stimulation of Toll-like receptor 5 and NOD1 strongly potentiates activity of NF-κB, resulting in enhanced innate immune reactions and resistance to Salmonella enterica serovar Typhimurium infection.

Authors:  Amir I Tukhvatulin; Ilya I Gitlin; Dmitry V Shcheblyakov; Natalia M Artemicheva; Lyudmila G Burdelya; Maxim M Shmarov; Boris S Naroditsky; Andrei V Gudkov; Alexander L Gintsburg; Denis Y Logunov
Journal:  Infect Immun       Date:  2013-07-29       Impact factor: 3.441

9.  NLR2 and TLR3, TLR4, TLR5 Ligands, Injected In Vivo, Improve after 1 h the Efficiency of Cloning and Proliferative Activity of Bone Marrow Multipotent Stromal Cells and Reduce the Content of Osteogenic Multipotent Stromal Cells in CBA Mice.

Authors:  Yu F Gorskaya; A I Tukhvatulin; V G Nesterenko
Journal:  Bull Exp Biol Med       Date:  2017-07-25       Impact factor: 0.804

10.  Type I and III interferons disrupt lung epithelial repair during recovery from viral infection.

Authors:  Jack Major; Stefania Crotta; Miriam Llorian; Teresa M McCabe; Hans Henrik Gad; Simon L Priestnall; Rune Hartmann; Andreas Wack
Journal:  Science       Date:  2020-06-11       Impact factor: 47.728

View more
  1 in total

Review 1.  Regulation of Immune Homeostasis via Muramyl Peptides-Low Molecular Weight Bioregulators of Bacterial Origin.

Authors:  Svetlana V Guryanova
Journal:  Microorganisms       Date:  2022-07-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.